Literature DB >> 31126920

Interpretation of Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine.

Clifford G Banda1,2,3, Karen I Barnes2,3, Gary Maartens4.   

Abstract

Entities:  

Keywords:  antiretroviral therapy; artemether-lumefantrine; artemisinin-based combination therapy; artesunate-amodiaquine; dolutegravir; integrase strand transfer inhibitor

Mesh：

Substances：

Year:  2019        PMID： 31126920      PMCID： PMC6535535          DOI： 10.1128/AAC.00576-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  3 in total

1.  Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial.

Authors:  Jan van Lunzen; Franco Maggiolo; José R Arribas; Aza Rakhmanova; Patrick Yeni; Benjamin Young; Jürgen K Rockstroh; Steve Almond; Ivy Song; Cindy Brothers; Sherene Min
Journal:  Lancet Infect Dis       Date:  2011-10-20       Impact factor: 25.071

2.  Linezolid Pharmacokinetics in South African Patients with Drug-Resistant Tuberculosis and a High Prevalence of HIV Coinfection.

Authors:  Sean Wasserman; Paolo Denti; James C M Brust; Mahmoud Abdelwahab; Siphokazi Hlungulu; Lubbe Wiesner; Jennifer Norman; Frederick A Sirgel; Robin M Warren; Aliasgar Esmail; Keertan Dheda; Neel R Gandhi; Graeme Meintjes; Gary Maartens
Journal:  Antimicrob Agents Chemother       Date:  2019-02-26       Impact factor: 5.191

3.  Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine.

Authors:  Stephen I Walimbwa; Mohammed Lamorde; Catriona Waitt; Julian Kaboggoza; Laura Else; Pauline Byakika-Kibwika; Alieu Amara; Joshua Gini; Markus Winterberg; Justin Chiong; Joel Tarning; Saye H Khoo
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.